Objective: Thyroid fine-needle aspiration cytology (FNAC) is the most valuable, cost-effective and accurate method for the evaluation of patients with thyroid nodules. One of its limitations is that up to 20% of results are nondiagnostic or unsatisfactory. The aim of this study was to analyze the number of thyroid FNAC specimens with nondiagnostic results obtained on an outpatient basis and how many of these had to be repeated according to their results. Study Design: This was a retrospective analysis of diagnostic reports of nondiagnostic thyroid FNAC specimens obtained between 1 January 2004 and 31 December 2012 which were retrieved by means of a computerized search. The FNAC results and the age and sex of the patients were collected. Results: From a total of 15,292 thyroid FNAC specimens, 6.8% (n = 1,033) corresponded to nondiagnostic cases. Eligible diagnostic reports for analysis included 877 cases (106 were repetitions of previous nondiagnostic FNAC). After an initial nondiagnostic finding for 771 FNAC smears, 29.5% (n = 225) were repeated with the following results: 43.6% insufficient, 49.3% benign, 6.2% follicular neoplasm, 0.4% suspicious for malignancy and 0.4% malignant. Twenty-two patients underwent a second repeated FNAC. Here the findings were: 36.4% insufficient, 59.1% benign, 4.5% follicular neoplasm, 0.0% suspicious for malignancy and 0.0% malignant. Conclusions: There was a low rate of repeated FNAC among the group of nondiagnostic cases. With repeated FNAC, the rate of nondiagnostic cases and the number of results that potentially demand surgery diminish.

1.
Ghassi D, Donato A: Evaluation of the thyroid nodule. Postgrad Med J 2009;85:190-195.
2.
Bahn RS, Castro MR: Approach to the patient with nontoxic multinodular goiter. J Clin Endocrinol Metab 2011;96:1202-1212.
3.
Mijovic T, Rochon L, Gologan O, Hier MP, Black MJ, Young J, et al: Fine-needle aspiration biopsies in the management of indeterminate follicular and Hürthle cell thyroid lesions. Otolaryngol Head Neck Surg 2009;140:715-719.
4.
Al Maqbali T, Tedla M, Weickert MO, Mehanna H: Malignancy risk analysis in patients with inadequate fine needle aspiration cytology (FNAC) of the thyroid. PLoS One 2012;7:e49078.
5.
Cibas ES, Ali SZ: The Bethesda System for reporting thyroid cytopathology. Am J Clin Pathol 2009;132:658-665.
6.
Yang J, Schnadig V, Logrono R, Wasserman PG: Fine-needle aspiration of thyroid nodules: a study of 4703 patients with histologic and clinical correlations. Cancer 2007;111:306-315.
7.
Raab SS, Vrbin CM, Grzybicki DM, Sudilovsky D, Balassanian R, Zarbo RJ, et al: Errors in thyroid gland fine-needle aspiration. Am J Clin Pathol 2006;125:873-882.
8.
Gharib H, Papini E, Paschke R, Duick DS, Valcavi R, Hegedüs L, et al: American Association of Clinical Endocrinologists, Associazone Medici Endocrinologi and European Thyroid Association Medical Guidelines for clinical practice for diagnosis and management of thyroid nodules. Endocr Pract 2010;16:468-475.
9.
Ceresini G, Corcione L, Morganti S, Milli B, Bertone L, Prampolini R, et al: Ultrasound-guided fine-needle capillary biopsy of thyroid nodules, coupled with on-site cytologic review, improves results. Thyroid 2004;14:385-389.
10.
Orija IB, Pineyro M, Biscotti C, Reddy SS, Hamrahian AH: Value of repeating a non-diagnostic thyroid fine-needle aspiration biopsy. Endocr Pract 2007;13:735-742.
11.
Baloch Z, LiVolsi VA, Jain P, Jain R, Aljada I, Mandel S, et al: Role of repeat fine-needle aspiration biopsy (FNAB) in the management of thyroid nodules. Diagn Cytopathol 2003;29:203-206.
12.
Yoon JH, Moon HJ, Kim EK, Kwak JY: Inadequate cytology in thyroid nodules: should we repeat aspiration or follow-up? Ann Surg Oncol 2011;18:1282-1289.
13.
Kim DW, Lee EJ, Lee JH: Role of ultrasound diagnosis in assessing and managing thyroid nodules with inadequate cytology. AJR Am J Roentgenol 2011;197:1213-1219.
14.
Moon HJ, Kwak JY, Choi YS, Kim EK: How to manage thyroid nodules with two consecutive non-diagnostic results on ultrasonography-guided fine-needle aspiration. World J Surg 2012;36:586-592.
15.
Coorough N, Hudak K, Jaume JC, Buehler D, Selvaggi S, Rivas J, et al: Non-diagnostic fine-needle aspirations of the thyroid: is the risk of malignancy higher? J Surg Res 2013;184:746-750.
16.
Oertel YC, Miyahara-Felipe L, Mendoza MG, Yu K: Value of repeated thyroid fine needle aspirations: an analysis of over ten thousand FNAs. Thyroid 2007;17:1061-1066.
17.
Tabacchali MA, Hanson JM, Johnson SJ, Wadehra V, Lennard TW, Proud G: Thyroid aspiration cytology in Newcastle: a six-year cytology/histology correlation study. Ann R Coll Surg Engl 2000;82:149-155.
18.
Bongiovanni M, Spitale A, Faquin WC, Mazzuchelli L, Baloch ZW: The Bethesta system for reporting thyroid cytopathology: a meta-analysis. Acta Cytol 2012;56:333-339.
19.
Alexander EK, Heering JP, Benson CB, Frates MC, Doubilet PM, Cibas ES, et al: Assessment of nondiagnostic ultrasound-guided fine needle aspirations of thyroid nodules. J Clin Endocrinol Metab 2002;87:4924-4927.
20.
Choi SH, Han KH, Yoon JH, Moon HJ, Son EJ, Youk JH, et al: Factors affecting inadequate sampling of ultrasound-guided fine-needle aspiration biopsy of thyroid nodules. Clin Endocrinol 2011;74:776-782.
21.
Choi YS, Hong SW, Kwak JY, Moon HJ, Kim EK: Clinical and ultrasonographic findings affecting non-diagnostic results upon the second fine-needle aspiration for thyroid nodules. Ann Surg Oncol 2012;19:2304-2309.
22.
Richards ML, Bohnenblust E, Sirinek K, Bingener J: Non-diagnostic thyroid fine-needle aspiration biopsies are no longer a dilemma. Am J Surg 2008;196:398-402.
23.
Renshaw AA: Significance of repeatedly non-diagnostic thyroid fine-needle aspirations. Am J Clin Pathol 2011;135:750-752.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.